Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Enveric Biosciences, Inc. (ENVB) had Current Ratio of 5.38 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-4.04M |
|
-- |
|
-- |
|
$2.19M |
|
$-2.19M |
|
$-0.00M |
|
$-2.19M |
|
$-2.19M |
|
$-2.19M |
|
$-2.19M |
|
$-2.19M |
|
$-2.19M |
|
$-2.19M |
|
$-2.15M |
|
0.33M |
|
0.33M |
|
$0.86 |
|
$0.86 |
|
| Balance Sheet Financials | |
$4.94M |
|
$0.16M |
|
$0.16M |
|
$5.10M |
|
$0.92M |
|
-- |
|
-- |
|
$0.92M |
|
$4.18M |
|
$4.18M |
|
$4.18M |
|
1.06M |
|
| Cash Flow Statement Financials | |
$-8.14M |
|
-- |
|
$10.58M |
|
$2.24M |
|
$4.68M |
|
$2.44M |
|
$0.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
5.38 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.14M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-52.52% |
|
-52.52% |
|
-43.06% |
|
-52.52% |
|
$3.93 |
|
$-24.32 |
|
$-24.32 |
|